Biofrontera(CH:B8F)
CH:B8F
Biofrontera financials statements
Biofrontera (B8F) Ratios
0 Followers
Biofrontera Ratios
CH:B8F's free cash flow for Q4 2023 was €0.00. For the 2023 fiscal year, CH:B8F's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.43 | ― | 1.76 | 1.80 | 0.82 |
| Quick Ratio | 1.77 | ― | 1.26 | 1.22 | 0.55 |
| Cash Ratio | 0.63 | ― | 0.31 | 0.76 | 0.40 |
| Solvency Ratio | -0.57 | ― | 0.04 | -3.50 | 2.19 |
| Operating Cash Flow Ratio | -0.77 | ― | -0.19 | -0.46 | 1.74 |
| Short-Term Operating Cash Flow Coverage | -7.14 | ― | -4.10 | -8.73 | 12.43 |
| Net Current Asset Value | € 8.11M | ― | € 6.97M | € 2.67M | € -4.32M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | ― | 0.04 | 0.05 | 0.04 |
| Debt-to-Equity Ratio | 0.04 | ― | 0.06 | 0.07 | 0.06 |
| Debt-to-Capital Ratio | 0.04 | ― | 0.05 | 0.07 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | ― | 0.03 | 0.05 | 0.01 |
| Financial Leverage Ratio | 1.38 | ― | 1.54 | 1.61 | 1.33 |
| Debt Service Coverage Ratio | -9.97 | ― | 15.18 | 2.27 | -2.34 |
| Interest Coverage Ratio | -73.21 | ― | 318.80 | 9.75 | -4.27 |
| Debt to Market Cap | 0.04 | ― | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.11 | ― | 0.02 | 0.03 | 0.12 |
| Net Debt to EBITDA | 5.32 | ― | -0.35 | -2.09 | 0.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 82.71% | ― | 78.67% | 81.52% | 86.41% |
| EBIT Margin | -9.16% | ― | 14.83% | 6.18% | -55.17% |
| EBITDA Margin | -4.25% | ― | 17.28% | 9.08% | -43.74% |
| Operating Profit Margin | -7.77% | ― | 14.83% | 6.18% | -55.17% |
| Pretax Profit Margin | -9.27% | ― | 15.93% | -167.88% | 123.96% |
| Net Profit Margin | -30.06% | ― | -1.14% | -171.60% | 131.13% |
| Continuous Operations Profit Margin | -52.64% | ― | -1.14% | -171.60% | 131.13% |
| Net Income Per EBT | 324.47% | ― | -7.18% | 102.21% | 105.78% |
| EBT Per EBIT | 119.22% | ― | 107.44% | -2717.61% | -224.68% |
| Return on Assets (ROA) | -19.21% | ― | -1.20% | -134.96% | 49.58% |
| Return on Equity (ROE) | -26.60% | ― | -1.85% | -217.18% | 65.73% |
| Return on Capital Employed (ROCE) | -6.87% | ― | 23.15% | 6.53% | -27.07% |
| Return on Invested Capital (ROIC) | -6.58% | ― | 22.08% | 6.42% | -24.66% |
| Return on Tangible Assets | -19.21% | ― | -1.25% | -140.09% | 50.34% |
| Earnings Yield | -26.74% | ― | -0.07% | -2.40% | 2.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.19 | ― | 4.38 | 11.61 | 18.91 |
| Payables Turnover | 1.56 | ― | 2.65 | 2.40 | 1.43 |
| Inventory Turnover | 0.61 | ― | 1.36 | 0.99 | 0.81 |
| Fixed Asset Turnover | 19.98 | ― | 9.80 | 8.55 | 12.62 |
| Asset Turnover | 0.64 | ― | 1.05 | 0.79 | 0.38 |
| Working Capital Turnover Ratio | 1.89 | ― | 4.51 | 14.38 | 3.90 |
| Cash Conversion Cycle | 532.40 | ― | 215.08 | 247.09 | 213.22 |
| Days of Sales Outstanding | 166.43 | ― | 83.35 | 31.44 | 19.30 |
| Days of Inventory Outstanding | 599.69 | ― | 269.35 | 367.92 | 449.04 |
| Days of Payables Outstanding | 233.73 | ― | 137.62 | 152.26 | 255.12 |
| Operating Cycle | 766.12 | ― | 352.69 | 399.36 | 468.34 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.72 | ― | -0.03 | -0.07 | 0.53 |
| Free Cash Flow Per Share | -0.73 | ― | -0.04 | -0.08 | 0.51 |
| Dividend Paid and CapEx Coverage Ratio | -86.27 | ― | -2.10 | -3.97 | 48.39 |
| Capital Expenditure Coverage Ratio | -86.27 | ― | -2.10 | -3.97 | 48.39 |
| Operating Cash Flow Coverage Ratio | -7.03 | ― | -1.67 | -2.59 | 9.22 |
| Operating Cash Flow to Sales Ratio | -0.33 | ― | -0.06 | -0.15 | 1.06 |
| Free Cash Flow Yield | -30.02% | ― | -0.53% | -0.26% | 1.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.75 | ― | -1451.72 | -41.60 | 45.05 |
| Price-to-Sales (P/S) Ratio | 1.12 | ― | 16.66 | 71.53 | 59.80 |
| Price-to-Book (P/B) Ratio | 0.99 | ― | 26.89 | 90.53 | 29.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.33 | ― | -189.91 | -377.55 | 57.75 |
| Price-to-Operating Cash Flow Ratio | -3.37 | ― | -280.26 | -472.64 | 56.55 |
| Price-to-Earnings Growth (PEG) Ratio | 0.39 | ― | 14.63 | 0.19 | -0.11 |
| Enterprise Value Multiple | -21.16 | ― | 96.06 | 785.64 | -136.42 |
| Enterprise Value | 11.85M | ― | 535.32M | 1.84B | 1.72B |
| EV to EBITDA | -21.16 | ― | 96.06 | 785.64 | -136.42 |
| EV to Sales | 0.90 | ― | 16.60 | 71.34 | 59.67 |
| EV to Free Cash Flow | -2.66 | ― | -189.23 | -376.55 | 57.62 |
| EV to Operating Cash Flow | -2.69 | ― | -279.25 | -471.39 | 56.43 |
| Tangible Book Value Per Share | 2.44 | ― | 0.30 | 0.33 | 0.97 |
| Shareholders’ Equity Per Share | 2.45 | ― | 0.31 | 0.35 | 0.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -4.68 | ― | -0.34 | -0.02 | 0.05 |
| Revenue Per Share | 2.17 | ― | 0.51 | 0.45 | 0.50 |
| Net Income Per Share | -0.65 | ― | -0.01 | -0.77 | 0.65 |
| Tax Burden | 3.24 | ― | -0.07 | 1.02 | 1.06 |
| Interest Burden | 1.01 | ― | 1.07 | -27.16 | -2.25 |
| Research & Development to Revenue | 0.17 | ― | 0.24 | 0.28 | 0.24 |
| SG&A to Revenue | 0.72 | ― | 0.41 | 0.48 | 1.85 |
| Stock-Based Compensation to Revenue | 0.00 | ― | 0.00 | 0.00 | 0.00 |
| Income Quality | -2.14 | ― | 5.20 | 0.09 | 0.85 |
Currency in EUR
